Item 1. Financial Statements
76K characters. Original on sec.gov · Markdown
Item 1. Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
($ in millions, unless otherwise stated)
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Revenue | 3,181 | 2,835 | |||||||||||||||||||||
| Cost of revenue | (1,393) | (1,275) | |||||||||||||||||||||
| Gross profit | 1,788 | 1,560 | |||||||||||||||||||||
| Research and development | (588) | (547) | |||||||||||||||||||||
| Selling, general and administrative | (284) | (281) | |||||||||||||||||||||
| Amortization of acquisition-related intangible assets | (32) | (27) | |||||||||||||||||||||
| Total operating expenses | (904) | (855) | |||||||||||||||||||||
| Other income (expense) | 621 | 18 | |||||||||||||||||||||
| Operating income (loss) | 1,505 | 723 | |||||||||||||||||||||
| Financial income (expense): | |||||||||||||||||||||||
| Other financial income (expense) | (96) | (92) | |||||||||||||||||||||
| Income (loss) before income taxes | 1,409 | 631 | |||||||||||||||||||||
| Benefit (provision) for income taxes | (272) | (130) | |||||||||||||||||||||
| Results relating to equity-accounted investees | (4) | (4) | |||||||||||||||||||||
| Net income (loss) | 1,133 | 497 | |||||||||||||||||||||
| Less: Net income (loss) attributable to non-controlling interests | 11 | 7 | |||||||||||||||||||||
| Net income (loss) attributable to stockholders | 1,122 | 490 | |||||||||||||||||||||
| Earnings per share data: | |||||||||||||||||||||||
| Net income (loss) per common share attributable to stockholders in $ | |||||||||||||||||||||||
| Basic | 4.44 | 1.93 | |||||||||||||||||||||
| Diluted | 4.43 | 1.92 | |||||||||||||||||||||
| Weighted average number of shares of common stock outstanding during the period (in thousands): | |||||||||||||||||||||||
| Basic | 252,715 | 253,709 | |||||||||||||||||||||
| Diluted | 253,525 | 255,018 |
See accompanying notes to the Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
($ in millions, unless otherwise stated)
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Net income (loss) | 1,133 | 497 | |||||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Change in fair value cash flow hedges | (4) | 3 | |||||||||||||||||||||
| Change in foreign currency translation adjustment | (37) | 43 | |||||||||||||||||||||
| Change in net actuarial gain (loss) | (1) | — | |||||||||||||||||||||
| Total other comprehensive income (loss) | (42) | 46 | |||||||||||||||||||||
| Total comprehensive income (loss) | 1,091 | 543 | |||||||||||||||||||||
| Less: Comprehensive income (loss) attributable to non-controlling interests | 11 | 7 | |||||||||||||||||||||
| Total comprehensive income (loss) attributable to stockholders | 1,080 | 536 |
See accompanying notes to the Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
($ in millions, unless otherwise stated)
| March 29, 2026 | December 31, 2025 | |||||||||||||
| ASSETS | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | 3,708 | 3,267 | ||||||||||||
| Accounts receivable, net | 1,186 | 1,055 | ||||||||||||
| Assets held for sale | 91 | 372 | ||||||||||||
| Inventories, net | 2,523 | 2,577 | ||||||||||||
| Other current assets | 644 | 669 | ||||||||||||
| Total current assets | 8,152 | 7,940 | ||||||||||||
| Non-current assets: | ||||||||||||||
| Deferred tax assets | 1,238 | 1,213 | ||||||||||||
| Other non-current assets | 3,037 | 2,584 | ||||||||||||
| Property, plant and equipment, net of accumulated depreciation of $6,457 and $6,366 respectively | 2,901 | 2,977 | ||||||||||||
| Identified intangible assets, net of accumulated amortization of $775 and $820 respectively | 1,505 | 1,547 | ||||||||||||
| Goodwill | 10,280 | 10,299 | ||||||||||||
| Total non-current assets | 18,961 | 18,620 | ||||||||||||
| Total assets | 27,113 | 26,560 | ||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | 904 | 997 | ||||||||||||
| Restructuring liabilities-current | 133 | 189 | ||||||||||||
| Other current liabilities | 1,851 | 1,445 | ||||||||||||
| Short-term debt | 750 | 1,250 | ||||||||||||
| Total current liabilities | 3,638 | 3,881 | ||||||||||||
| Non-current liabilities: | ||||||||||||||
| Long-term debt | 10,974 | 10,972 | ||||||||||||
| Restructuring liabilities | 76 | 81 | ||||||||||||
| Other non-current liabilities | 1,151 | 1,175 | ||||||||||||
| Total non-current liabilities | 12,201 | 12,228 | ||||||||||||
| Total liabilities | 15,839 | 16,109 | ||||||||||||
| Equity: | ||||||||||||||
| Non-controlling interests | 347 | 395 | ||||||||||||
| Stockholders’ equity: | ||||||||||||||
| Common stock, par value €0.20 per share: | 56 | 56 | ||||||||||||
| Capital in excess of par value | 15,537 | 15,424 | ||||||||||||
| Treasury shares, at cost: | ||||||||||||||
| 21,894,272 shares (2025: 21,664,934 shares) | (4,341) | (4,283) | ||||||||||||
| Accumulated other comprehensive income (loss) | 171 | 213 | ||||||||||||
| Accumulated deficit | (496) | (1,354) | ||||||||||||
| Total stockholders’ equity | 10,927 | 10,056 | ||||||||||||
| Total equity | 11,274 | 10,451 | ||||||||||||
| Total liabilities and equity | 27,113 | 26,560 |
See accompanying notes to the Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
($ in millions, unless otherwise stated)
| For the three months ended | |||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income (loss) | 1,133 | 497 | |||||||||
| Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities: | |||||||||||
| Depreciation and amortization | 179 | 209 | |||||||||
| Share-based compensation | 109 | 127 | |||||||||
| Amortization of discount (premium) on debt, net | 1 | 1 | |||||||||
| Amortization of debt issuance costs | 2 | 1 | |||||||||
| Net (gain) loss on sale of assets | (627) | (22) | |||||||||
| (Gain) loss on equity security, net | (1) | 6 | |||||||||
| Results relating to equity-accounted investees | 4 | 4 | |||||||||
| Deferred tax expense (benefit) | (28) | (27) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| (Increase) decrease in receivables and other current assets | (115) | (29) | |||||||||
| (Increase) decrease in inventories | 87 | 6 | |||||||||
| Increase (decrease) in accounts payable and other liabilities | 231 | (110) | |||||||||
| Decrease (increase) in other non-current assets | (182) | (106) | |||||||||
| Exchange differences | 4 | 4 | |||||||||
| Other items | (4) | 4 | |||||||||
| Net cash provided by (used for) operating activities | 793 | 565 | |||||||||
| Cash flows from investing activities: | |||||||||||
| Purchase of identified intangible assets | (42) | (25) | |||||||||
| Capital expenditures on property, plant and equipment | (79) | (139) | |||||||||
| Proceeds from disposals of property, plant and equipment | — | 1 | |||||||||
| Proceeds from sale of interests in businesses, net of cash divested | 878 | — | |||||||||
| Purchase of investments | (249) | (53) | |||||||||
| Net cash provided by (used for) investing activities | 508 | (216) | |||||||||
| Cash flows from financing activities: | |||||||||||
| Repurchase of long-term debt | (501) | — | |||||||||
| Proceeds from the issuance of long-term debt | — | 370 | |||||||||
| Cash paid for debt issuance costs | (3) | — | |||||||||
| Proceeds from issuance of commercial paper notes | — | 646 | |||||||||
| Repayment of commercial paper notes | — | (146) | |||||||||
| Dividends paid to non-controlling interests | (29) | — | |||||||||
| Dividends paid to common stockholders | (256) | (258) | |||||||||
| Proceeds from issuance of common stock through stock plans | 36 | 37 | |||||||||
| Purchase of treasury shares and restricted stock unit withholdings | (102) | (303) | |||||||||
| Other, net | (1) | (1) | |||||||||
| Net cash provided by (used for) financing activities | (856) | 345 | |||||||||
| Effect of changes in exchange rates on cash positions | (4) | 2 | |||||||||
| Increase (decrease) in cash and cash equivalents | 441 | 696 | |||||||||
| Cash and cash equivalents at beginning of period | 3,267 | 3,292 | |||||||||
| Cash and cash equivalents at end of period | 3,708 | 3,988 |
| Supplemental disclosures to the Condensed Consolidated Cash flows | |||||||||||
| Net cash paid during the period for: | |||||||||||
| Interest | 79 | 41 | |||||||||
| Income taxes, net of refunds | 93 | 96 | |||||||||
| Net gain (loss) on sale of assets: | |||||||||||
| Cash proceeds from the sale of assets | 878 | 31 | |||||||||
| Non-cash consideration 1) | 44 | — | |||||||||
| Book value of these assets and transaction costs | (295) | (9) | |||||||||
| Non-cash investing activities: | |||||||||||
| Non-cash capital expenditures | 87 | 108 |
- Represents the fair value on the closing date of the earn-out receivable from the divestiture of our MEMS Sensors business
See accompanying notes to the Condensed Consolidated Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Unaudited)
($ in millions, unless otherwise stated)
| Outstanding number of shares (in thousands) | Common stock | Capital in excess of par value | Treasury shares at cost | Accumu- lated other compre- hensive income (loss) | Accumu- lated deficit | Total stock- holders’ equity | Non- con- trolling interests | Total equity | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2025 | 252,854 | 56 | 15,424 | (4,283) | 213 | (1,354) | 10,056 | 395 | 10,451 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | 1,122 | 1,122 | 11 | 1,133 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | (42) | (42) | (42) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation plans | 113 | 113 | 113 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued pursuant to stock awards | 232 | 44 | (8) | 36 | 36 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Treasury shares repurchased and retired | (461) | (102) | (102) | (102) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends non-controlling interest | (59) | (59) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends common stock ($1.014 per share) | (256) | (256) | (256) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 29, 2026 | 252,625 | 56 | 15,537 | (4,341) | 171 | (496) | 10,927 | 347 | 11,274 | |||||||||||||||||||||||||||||||||||||||||||||||
| Outstanding number of shares (in thousands) | Common stock | Capital in excess of par value | Treasury shares at cost | Accumu- lated other compre- hensive income (loss) | Accumu- lated deficit | Total stock- holders’ equity | Non- con- trolling interests | Total equity | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2024 | 254,324 | 56 | 14,962 | (4,004) | (17) | (1,814) | 9,183 | 348 | 9,531 | |||||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | 490 | 490 | 7 | 497 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | 46 | 46 | 46 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-based compensation plans | 131 | 131 | 131 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares issued pursuant to stock awards | 238 | 54 | (22) | 32 | 32 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Treasury shares repurchased and retired | (1,413) | (303) | (303) | (303) | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends common stock ($1.014 per share) | (257) | (257) | (257) | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Balance as of March 30, 2025 | 253,149 | 56 | 15,093 | (4,253) | 29 | (1,603) | 9,322 | 355 | 9,677 | |||||||||||||||||||||||||||||||||||||||||||||||
See accompanying notes to the Condensed Consolidated Financial Statements
NXP SEMICONDUCTORS N.V.
NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
All amounts in millions of $ unless otherwise stated
1 Basis of Presentation and Overview
We prepared our interim Condensed Consolidated Financial Statements that accompany these notes in conformity with U.S. generally accepted accounting principles, consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended December 31, 2025.
Use of estimates
We have made estimates and judgments affecting the amounts reported in our Condensed Consolidated Financial Statements and the accompanying notes. The actual results that we experience may differ materially from our estimates. The interim financial information is unaudited, but reflects all normal adjustments that are, in our opinion, necessary to provide a fair statement of results for the interim periods presented. This interim information should be read in conjunction with the Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2025.
Segment reporting
NXP has one reportable segment representing the entity as a whole, aligning with our organizational structure and with the way our chief operating decision maker ("CODM"), the Chief Executive Officer, makes operating decisions, allocates resources, and manages the growth and profitability of the Company.
Our CODM regularly reviews income and expense items at the consolidated company (reporting segment) level and uses net income to evaluate income generated from total assets to evaluate whether and how to reinvest profits into the entity’s operations, shareholder return, acquisitions or otherwise. Net income is also used to monitor budget versus actual results, forecasted information and in competitive analysis. These interim income and expense items are included on the Consolidated Statements of Operations and in our notes to the Consolidated Financial Statements.
2 Significant Accounting Policies and Recent Accounting Pronouncements
Significant Accounting Policies
For a discussion of our significant accounting policies, see Part II – Item 8. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – “Significant Accounting Policies” of our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no changes to our significant accounting policies since our Annual Report on Form 10-K for the year ended December 31, 2025.
Recent accounting standards
Accounting standards not yet adopted
In November 2024, the FASB issued Accounting Standards Update (ASU) 2024-03, Disaggregation of Income Statement Expenses. The standard requires disaggregated disclosure of income statement expenses. It requires disaggregation of certain expense captions into specified categories in disclosures within the footnotes to the financial statements. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. We are currently evaluating the effect of this new guidance on our Consolidated Financial Statements.
No other new accounting pronouncements were issued or became effective in the period that had, or are expected to have, a material impact on our Consolidated Financial Statements.
3 Acquisitions and Divestments
2026
On February 2, 2026, we completed the sale of our MEMS Sensors business, previously classified as held for sale, pursuant to the definitive agreement with STMicroelectronics International N.V. dated July 24, 2025. At closing, we received $878 million in cash, with the potential to receive an additional $50 million contingent upon the achievement of specified post‑closing technical milestones ("earn-out receivable"). The earn-out receivable was measured at fair value at closing and included in the consideration transferred, with subsequent changes in fair value recognized in earnings. This resulted in a gain on sale of $627 million recorded in "Other income (expense)" in the Consolidated Statements of Operations.
There were no material acquisitions during the first three months of 2026.
2025
TTTech Auto acquisition
On June 17, 2025, NXP announced the closing of the acquisition of 100% of TTTech Auto for $766 million in cash ($675 million net of cash acquired). TTTech Auto is a leader in innovating unique safety-critical systems and middleware for software-defined vehicles (SDVs). The TTTech Auto acquisition complements and expands NXP’s system and software offerings in the Automotive and Industrial & IoT end markets.
The revised fair values of the assets acquired, and liabilities assumed in the TTTech Auto acquisition, by major class, were recognized as follows:
| Cash | 91 | ||||
| Other assets | 75 | ||||
| Other liabilities | (52) | ||||
| Identified intangible assets | 347 | ||||
| Goodwill | 305 | ||||
| Net assets acquired | 766 |
Our valuation procedures related to the acquired assets and assumed liabilities was completed during the first quarter of 2026.
Goodwill arising from the TTTech Auto acquisition is attributed to the anticipated growth from new product sales, sales to new customers, the assembled workforce, and synergies expected from the combination. The goodwill recognized is non-deductible for income tax purposes.
The identified intangible assets assumed were recognized as follows:
| Fair value | Weighted Average Estimated Useful Life (in Years) | |||||||||||||
| Software | 267 | 11.5 | ||||||||||||
| Technology | 25 | 11.5 | ||||||||||||
| Customer relationships | 50 | 8.5 | ||||||||||||
| Order backlog | 5 | 3.5 | ||||||||||||
| Total identified intangible assets | 347 | 10.9 |
The income approach was applied to estimate the fair values of the intangible assets acquired. Software, technology, customer relationships, and order backlog were valued using the excess earnings method, which reflects the present values of the projected cash flows that are expected to be generated by the software, technology, customer relationships, and order backlog less charges representing the contribution of other assets to those cash flows.
Aviva Links acquisition
On October 24, 2025, NXP closed the previously announced acquisition of 100% of Aviva Links for $222 million in cash ($202 million net of cash acquired) and $26 million through the settlement of previously held investments in Aviva Links. Aviva Links is a provider of Automotive SerDes Alliance (ASA) compliant in-vehicle connectivity solutions. The Aviva Links acquisition complements and expands NXP’s automotive networking solutions in the Automotive and Industrial & IoT end markets.
The fair values of the assets acquired, and liabilities assumed in the Aviva Links acquisition, by major class, were recognized as follows:
| Other assets | 20 | ||||
| Other liabilities | (64) | ||||
| In-Process R&D ("IPR&D") | 197 | ||||
| Goodwill | 95 | ||||
| Net assets acquired | 248 |
The purchase price allocation contains valuations related to certain assets and liabilities as some of the estimates and assumptions are subject to change within the measurement period as additional information becomes available.
Goodwill arising from the Aviva Links acquisition is attributed to the value related to new technological innovations from future product sales, sales to new customers, the assembled workforce, and synergies expected from the combination. The goodwill recognized is non-deductible for income tax purposes.
Acquired IPR&D is an intangible asset classified as an indefinite lived asset until the completion or abandonment of the associated research and development effort. IPR&D will be amortized over an estimated useful life to be determined at the date the associated research and development effort is completed, or expensed immediately when, and if, the project is abandoned. Acquired IPR&D is not amortized during the period that it is considered indefinite lived, but rather is subject to annual testing for impairment or when there are indicators for impairment.
The excess earnings method, a variant of the income approach, was applied to estimate the fair value of the IPR&D acquired. The fair value represents the present value of the projected cash flows that are expected to be generated by the IPR&D, adjusted for contributory asset charges related to other acquired assets.
Kinara, Inc. acquisition
On October 27, 2025, NXP closed the previously announced acquisition of 100% of Kinara, Inc. for $284 million in cash ($283 million net of cash acquired). Kinara is an industry leader in high performance, energy-efficient and programmable discrete neural processing units (NPUs). The Kinara acquisition complements and expands NXP’s solutions for AI-powered edge systems in the Industrial & IoT and Automotive end markets.
The revised fair values of the assets acquired, and liabilities assumed in the Kinara acquisition, by major class, were recognized as follows:
| Other assets | 8 | ||||
| Other liabilities | (59) | ||||
| Identified intangible assets | 254 | ||||
| Goodwill | 81 | ||||
| Net assets acquired | 284 |
The purchase price allocation contains valuations related to certain assets and liabilities as some of the estimates and assumptions are subject to change within the measurement period as additional information becomes available.
Goodwill arising from the Kinara acquisition is attributed to the value related to new technological innovations from future product sales, sales to new customers, the assembled workforce, and synergies expected from the combination. The goodwill recognized is non-deductible for income tax purposes.
The identified intangible assets assumed were recognized as follows:
| Fair value | Weighted Average Estimated Useful Life (in Years) | |||||||||||||
| Existing Technology | 191 | 9.2 | ||||||||||||
| IPR&D1 | 56 | N/A | ||||||||||||
| Customer relationships | 7 | 8.2 | ||||||||||||
| Total identified intangible assets | 254 | 9.2 |
1 IPR&D is an intangible asset classified as an indefinite lived asset until the completion or abandonment of the associated research and development effort. IPR&D will be amortized over an estimated useful life to be determined at the date the associated research and development effort is completed, or expensed immediately when, and if, the project is abandoned. Acquired IPR&D is not amortized during the period that it is considered indefinite lived, but rather is subject to annual testing for impairment or when there are indicators for impairment.
The excess earnings method, a variant of the income approach, was applied to estimate the fair values of the technology and IPR&D. The fair values represent the present values of the projected cash flows that are expected to be generated by the technology or IPR&D, adjusted for contributory asset charges related to other acquired assets. In addition, the existing customer relationships are valued using the distributor method, a variant of the income approach, in which a market-based distributor profit margin is used to allocate profits to this intangible asset.
Divestments
There were no material divestments during 2025.
4 Assets Held for Sale
During the fourth quarter of 2025, NXP management committed to selling the buildings and land at our Oak Hill site in Austin, Texas. The carrying amount of the site of $74 million was classified as held for sale and continues to be presented within current assets, representing the majority of the assets classified as held for sale as of March 29, 2026. The asset is available for immediate sale, is being actively marketed, and management expects the sale to be completed within the next six months.
5 Supplemental Financial Information
Statement of Operations Information:
Disaggregation of revenue
The following table presents revenue disaggregated by sales channel:
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Distributors | 1,862 | 1,524 | |||||||||||||||||||||
| Direct | 1,282 | 1,284 | |||||||||||||||||||||
| Other | 37 | 27 | |||||||||||||||||||||
| Total - Revenue | 3,181 | 2,835 |
Depreciation, amortization and impairment
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Depreciation of property, plant and equipment | 109 | 143 | |||||||||||||||||||||
| Amortization of internal use software | 13 | 8 | |||||||||||||||||||||
| Amortization of other identified intangible assets | 57 | 58 | |||||||||||||||||||||
| Total - Depreciation, amortization and impairment | 179 | 209 |
Financial income and expense
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Interest income | 31 | 35 | |||||||||||||||||||||
| Interest expense | (114) | (106) | |||||||||||||||||||||
| Other financial income (expense) | (13) | (21) | |||||||||||||||||||||
| Total - Financial income (expense) | (96) | (92) |
Earnings per share
The computation of earnings per share (EPS) is presented in the following table:
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Net income (loss) | 1,133 | 497 | |||||||||||||||||||||
| Less: net income (loss) attributable to non-controlling interests | 11 | 7 | |||||||||||||||||||||
| Net income (loss) attributable to stockholders | 1,122 | 490 | |||||||||||||||||||||
| Weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) | 252,715 | 253,709 | |||||||||||||||||||||
| Plus incremental shares from assumed conversion of: | |||||||||||||||||||||||
| Options 1) | 4 | 94 | |||||||||||||||||||||
| Restricted Share Units, Performance Share Units and Equity Rights 2) | 806 | 1,215 | |||||||||||||||||||||
| Dilutive potential common shares | 810 | 1,309 | |||||||||||||||||||||
| Adjusted weighted average number of shares outstanding (after deduction of treasury shares) during the year (in thousands) | 253,525 | 255,018 | |||||||||||||||||||||
| EPS attributable to stockholders in $: | |||||||||||||||||||||||
| Basic net income (loss) | 4.44 | 1.93 | |||||||||||||||||||||
| Diluted net income (loss) | 4.43 | 1.92 |
-
There were no stock options to purchase shares of NXP’s common stock that were outstanding in Q1 2026 (Q1 2025: no stock options to purchase shares) that were anti-dilutive and were not included in the computation of diluted EPS because the exercise price was greater than the average fair market value of the common stock or the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense and exercise prices were greater than the weighted average number of shares underlying outstanding stock options.
-
There were no unvested RSUs, PSUs and equity rights that were outstanding in Q1 2026 (Q1 2025: no unvested RSU's, PSU's and equity rights) that were anti-dilutive and were not included in the computation of diluted EPS because the number of shares assumed to be repurchased using the proceeds of unrecognized compensation expense were greater than the weighted average number of outstanding unvested RSUs, PSUs and equity rights or the performance goal has not been met.
Balance Sheet Information
Cash and cash equivalents
At March 29, 2026, and December 31, 2025, our cash balance was $3,708 million and $3,267 million, respectively, of which $326 million and $361 million was held by SSMC, our consolidated joint venture company with TSMC. Under the terms of our joint venture agreement with TSMC, a portion of this cash can be distributed by way of a dividend to us, but 38.8% of the dividend will be paid to our joint venture partner. During 2025, no dividend was paid by SSMC. During the first quarter of 2026, SSMC declared a dividend of $150 million, of which $75 million was paid in the first quarter, with 38.8% being paid to our joint venture partner.
Inventories
Inventories are summarized as follows:
| March 29, 2026 | December 31, 2025 | ||||||||||
| Raw materials | 97 | 92 | |||||||||
| Work in process | 1,802 | 1,778 | |||||||||
| Finished goods | 624 | 707 | |||||||||
| 2,523 | 2,577 |
The amounts recorded above are net of allowance for obsolescence of $141 million as of March 29, 2026 (December 31, 2025: $152 million).
Equity Investments
At March 29, 2026, and December 31, 2025, the total carrying value of investments in equity securities is summarized as follows:
| March 29, 2026 | December 31, 2025 | ||||||||||
| Marketable equity securities | 2 | 1 | |||||||||
| Non-marketable equity securities | 162 | 118 | |||||||||
| Equity-accounted investments | 1,017 | 826 | |||||||||
| 1,181 | 945 |
The total carrying value of investments in equity-accounted investees is summarized as follows:
| March 29, 2026 | December 31, 2025 | |||||||||||||||||||||||||
| Shareholding % | Amount | Shareholding % | Amount | |||||||||||||||||||||||
| VisionPower Semiconductor Manufacturing Company Pte. Ltd. (VSMC) | 40.00 | % | 817 | 40.00 | % | 623 | ||||||||||||||||||||
| European Semiconductor Manufacturing Company (ESMC) GmbH 1) | 10.00 | % | 176 | 10.00 | % | 180 | ||||||||||||||||||||
| Others | — | 24 | — | 23 | ||||||||||||||||||||||
| 1,017 | 826 | |||||||||||||||||||||||||
| 1) NXP accounts for its investment in ESMC under the equity method due to our ability to exercise significant influence over ESMC’s operations, primarily through representation on ESMC’s shareholders’ committee and other operational arrangements. | ||||||||||||||||||||||||||
Results related to equity-accounted investees at the end of each period were as follows:
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Company's share in income (loss) | (4) | (4) | |||||||||||||||||||||
| Other results | — | — | |||||||||||||||||||||
| (4) | (4) |
Other current liabilities
Other current liabilities at March 29, 2026, and December 31, 2025, consisted of the following:
| March 29, 2026 | December 31, 2025 | ||||||||||
| Accrued compensation and benefits | 470 | 393 | |||||||||
| Dividend payable | 256 | 256 | |||||||||
| Customer programs | 150 | 57 | |||||||||
| Income taxes payable | 260 | 83 | |||||||||
| Other | 715 | 656 | |||||||||
| 1,851 | 1,445 |
Accumulated other comprehensive income (loss)
Total comprehensive income (loss) represents net income (loss) plus the results of certain equity changes not reflected in the Condensed Consolidated Statements of Operations. The after-tax components of accumulated other comprehensive income (loss) and their corresponding changes are shown below:
| Currency translation differences | Change in fair value cash flow hedges | Net actuarial gain/(losses) | Accumulated Other Comprehensive Income (loss) | ||||||||||||||||||||
| As of December 31, 2025 | 247 | 2 | (36) | 213 | |||||||||||||||||||
| Other comprehensive income (loss) before reclassifications | (37) | (3) | (1) | (41) | |||||||||||||||||||
| Amounts reclassified out of accumulated other comprehensive income (loss) | — | (2) | — | (2) | |||||||||||||||||||
| Tax effects | — | 1 | — | 1 | |||||||||||||||||||
| Other comprehensive income (loss) | (37) | (4) | (1) | (42) | |||||||||||||||||||
| As of March 29, 2026 | 210 | (2) | (37) | 171 |
Cash dividends
The following dividends were declared during the first three months of 2026 and 2025 under NXP’s quarterly dividend program:
| Fiscal Year 2026 | Fiscal Year 2025 | ||||||||||||||||||||||
| Dividend per share | Amount | Dividend per share | Amount | ||||||||||||||||||||
| First quarter | 1.014 | 256 | 1.014 | 257 | |||||||||||||||||||
The dividend declared in the first quarter (not yet paid) is classified in the Condensed Consolidated Balance Sheet in other current liabilities as of March 29, 2026, and was subsequently paid on April 9, 2026.
6 Restructuring
At each reporting date, we evaluate our restructuring liabilities, which consist primarily of termination benefits, to ensure that our accruals are still appropriate.
The following table presents the changes in restructuring liabilities in 2026:
| As of January 1, 2026 | Additions | Utilized | Released | Other changes | As of March 29, 2026 | ||||||||||||||||||||||||||||||
| Restructuring liabilities | 270 | 3 | (62) | (1) | (1) | 209 |
The total restructuring liability as of March 29, 2026, of $209 million is classified in the Consolidated Balance Sheet under current liabilities ($133 million) and non-current liabilities ($76 million).
The Company has ongoing restructuring initiatives aimed at streamlining manufacturing capacity, reducing costs, and aligning resources with strategic priorities. These initiatives primarily consist of workforce reductions, facility consolidations, and other cost‑saving measures. During the first quarter of 2026, the restructuring provision decreased by $61 million, primarily reflecting the execution of previously announced involuntary restructuring programs. The restructuring charges for the three-month period ending March 30, 2025 primarily consist of $14 million for personnel related costs for specific targeted actions.
These restructuring charges recorded in operating income, for the periods indicated, are included in the following line items in the Statement of Operations:
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Cost of revenue | (1) | 4 | |||||||||||||||||||||
| Research and development | 2 | 7 | |||||||||||||||||||||
| Selling, general and administrative | 1 | 3 | |||||||||||||||||||||
| Net restructuring charges | 2 | 14 |
7 Income Tax
Each year, NXP makes an estimate of its annual effective tax rate. This estimated annual effective tax rate ("EAETR") is then applied to the year-to-date income (loss) before income taxes excluding discrete items, to determine the year-to-date benefit (provision) for income taxes. The income tax effects of any discrete items are recognized in the interim period in which they occur. As the year progresses, the Company continually refines the EAETR based upon actual events and the apportionment of our earnings (loss). This continual estimation process periodically may result in a change to our EAETR for the year. When this occurs, we adjust on an accumulated basis the benefit (provision) for income taxes during the quarter in which the change occurs.
Our provision for income taxes for 2026 is based on our EAETR of 19.9%, which is lower than the Netherlands statutory tax rate of 25.8%, primarily due to tax benefits from the Netherlands and foreign tax incentives.
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Tax benefit (provision) calculated at EAETR | (280) | (119) | |||||||||||||||||||||
| Discrete tax benefit (provision) items | 8 | (11) | |||||||||||||||||||||
| Benefit (provision) for income taxes | (272) | (130) | |||||||||||||||||||||
| Effective tax rate | 19.3 | % | 20.6 | % |
The effective tax rate of 19.3% for the first quarter of 2026 was lower than the EAETR due to the income tax benefit for discrete items of $8 million. The discrete items are primarily related to the impact of foreign currency on income tax related items and changes in estimates for previous years.
The effective tax rate for the first quarter of 2026 was 19.3% compared to 20.6% for the same period in 2025, with discrete items in the respective periods impacting the rates accordingly. Excluding discrete items, the EAETR increased to 19.9% in 2026 from 18.8% in 2025, mainly as a result of a taxable capital gain and non-deductible goodwill associated with the divestiture of the MEMS Sensors business in the first quarter of 2026.
8 Identified Intangible Assets
Identified intangible assets as of March 29, 2026, and December 31, 2025, respectively, were composed of the following:
| March 29, 2026 | December 31, 2025 | ||||||||||||||||||||||
| Gross carrying amount | Accumulated amortization | Gross carrying amount | Accumulated amortization | ||||||||||||||||||||
| In-process R&D (IPR&D) 1) | 277 | — | 276 | — | |||||||||||||||||||
| Customer-related | 834 | (441) | 835 | (428) | |||||||||||||||||||
| Technology-based | 1,169 | (334) | 1,256 | (392) | |||||||||||||||||||
| Identified intangible assets | 2,280 | (775) | 2,367 | (820) | |||||||||||||||||||
| 1) IPR&D is not subject to amortization until completion or abandonment of the associated research and development effort. |
The estimated amortization expense for these identified intangible assets for each of the five succeeding years is:
| 2026 (remaining) | 208 | ||||
| 2027 | 254 | ||||
| 2028 | 195 | ||||
| 2029 | 131 | ||||
| 2030 | 126 | ||||
| Thereafter | 590 |
All intangible assets, excluding IPR&D and goodwill, are subject to amortization and have no assumed residual value.
The expected weighted average remaining life of identified intangibles is 7 years as of March 29, 2026 (December 31, 2025: 7 years).
9 Debt
Commercial Paper
We have a $2 billion Commercial Paper Program to support general corporate purposes. As of March 29, 2026, we had no commercial paper notes outstanding (December 31, 2025: no notes outstanding).
Debt issuance and redemption
On January 5, 2026, we repaid the $500 million aggregate principal amount of outstanding 5.35% senior unsecured notes due March 1, 2026, at par using available cash.
On February 6, 2026, NXP B.V., together with NXP Funding LLC, amended and restated its revolving credit agreement entered into on August 26, 2022. The amended and restated revolving credit agreement provides for $3 billion of senior unsecured revolving credit commitments and is scheduled to mature on February 6, 2031.
On April 20, 2026, we repaid $750 million aggregate principal amount of outstanding 3.875% senior unsecured notes due June 18, 2026, at par using available cash.
Long-term debt
The following table summarizes the outstanding debt as of March 29, 2026, and December 31, 2025:
| March 29, 2026 | December 31, 2025 | ||||||||||||||||||||||||||||
| Maturities | Amount | Interest rate | Amount | Interest rate | |||||||||||||||||||||||||
| Fixed-rate 5.35% senior unsecured notes | Mar, 2026 | — | 5.350 | 500 | 5.350 | ||||||||||||||||||||||||
| Fixed-rate 3.875% senior unsecured notes | Jun, 2026 | 750 | 3.875 | 750 | 3.875 | ||||||||||||||||||||||||
| Fixed-rate 3.15% senior unsecured notes | May, 2027 | 500 | 3.150 | 500 | 3.150 | ||||||||||||||||||||||||
| Fixed-rate 4.40% senior unsecured notes | Jun, 2027 | 500 | 4.400 | 500 | 4.400 | ||||||||||||||||||||||||
| Fixed-rate 4.30% senior unsecured notes | Aug, 2028 | 500 | 4.300 | 500 | 4.300 | ||||||||||||||||||||||||
| Fixed-rate 5.55% senior unsecured notes | Dec, 2028 | 500 | 5.550 | 500 | 5.550 | ||||||||||||||||||||||||
| Fixed-rate 4.3% senior unsecured notes | Jun, 2029 | 1,000 | 4.300 | 1,000 | 4.300 | ||||||||||||||||||||||||
| Fixed-rate 3.4% senior unsecured notes | May, 2030 | 1,000 | 3.400 | 1,000 | 3.400 | ||||||||||||||||||||||||
| Fixed-rate 2.5% senior unsecured notes | May, 2031 | 1,000 | 2.500 | 1,000 | 2.500 | ||||||||||||||||||||||||
| Fixed-rate 2.65% senior unsecured notes | Feb, 2032 | 1,000 | 2.650 | 1,000 | 2.650 | ||||||||||||||||||||||||
| Fixed-rate 4.85% senior unsecured notes | Aug, 2032 | 300 | 4.850 | 300 | 4.850 | ||||||||||||||||||||||||
| Fixed-rate 5.0% senior unsecured notes | Jan, 2033 | 1,000 | 5.000 | 1,000 | 5.000 | ||||||||||||||||||||||||
| Fixed-rate 5.25% senior unsecured notes | Aug, 2035 | 700 | 5.250 | 700 | 5.250 | ||||||||||||||||||||||||
| Fixed-rate 3.25% senior unsecured notes | May, 2041 | 1,000 | 3.250 | 1,000 | 3.250 | ||||||||||||||||||||||||
| Fixed-rate 3.125% senior unsecured notes | Feb, 2042 | 499 | 3.125 | 500 | 3.125 | ||||||||||||||||||||||||
| Fixed-rate 3.25% senior unsecured notes | Nov, 2051 | 500 | 3.250 | 500 | 3.250 | ||||||||||||||||||||||||
| Floating-rate revolving credit facility (RCF) | Aug, 2027 | — | — | — | — | ||||||||||||||||||||||||
| Fixed-rate 4.45% EIB Facility A Loan | Dec, 2030 | 670 | 4.450 | 670 | 4.450 | ||||||||||||||||||||||||
| Fixed-rate 4.709% EIB Facility B Loan | Feb, 2031 | 370 | 4.709 | 370 | 4.709 | ||||||||||||||||||||||||
| Total principal | 11,789 | 12,290 | |||||||||||||||||||||||||||
| Unamortized discounts, premiums and debt issuance costs | (65) | (68) | |||||||||||||||||||||||||||
| Total debt, including unamortized discounts, premiums, debt issuance costs and fair value adjustments | 11,724 | 12,222 | |||||||||||||||||||||||||||
| Current portion of long-term debt | (750) | (1,250) | |||||||||||||||||||||||||||
| Long-term debt | 10,974 | 10,972 | |||||||||||||||||||||||||||
10 Related-Party Transactions
The Company's related parties are the members of the board of directors of NXP Semiconductors N.V., the executive officers of NXP Semiconductors N.V. and equity-accounted investees.
The following table presents the amounts related to revenue and other income and purchase of goods and services incurred in transactions with these related parties:
| For the three months ended | |||||||||||||||||||||||
| March 29, 2026 | March 30, 2025 | ||||||||||||||||||||||
| Revenue and other income | 1 | 1 | |||||||||||||||||||||
| Purchase of goods and services | 1 | 1 |
The following table presents the amounts related to receivable and payable balances with these related parties:
| March 29, 2026 | December 31, 2025 | ||||||||||
| Receivables | — | 1 | |||||||||
| Payables | 3 | 3 |
Driven by our investment in VSMC, NXP has committed to contribute $1,200 million to support the long-term capacity infrastructure, and in exchange NXP secures a capacity commitment over the lifetime of the factory. NXP has contributed $189 million during the three months ended March 29, 2026, and $1,044 million to-date, which is recorded in other non-current assets.
Refer to Note 5 – Supplemental Financial Information for information on the total carrying value of investments in equity-accounted investees, and to Note 12 – Commitments and Contingencies for NXP’s related party commitments.
11 Fair Value Measurements
The following table summarizes the estimated fair value of our financial instruments which are measured at fair value on a recurring basis:
| Estimated fair value | |||||||||||||||||
| Fair value hierarchy | March 29, 2026 | December 31, 2025 | |||||||||||||||
| Assets: | |||||||||||||||||
| Money market funds | 1 | 1,713 | 1,757 | ||||||||||||||
| Marketable equity securities | 1 | 2 | 1 | ||||||||||||||
| Derivative instruments-assets | 2 | 6 | 9 | ||||||||||||||
| Earn-out receivable | 3 | 44 | — | ||||||||||||||
| Liabilities: | |||||||||||||||||
| Derivative instruments-liabilities | 2 | (13) | (11) |
The following methods and assumptions were used to estimate the fair value of financial instruments:
Assets and liabilities measured at fair value on a recurring basis
Money market funds (as part of our cash and cash equivalents) and marketable equity securities (as part of other non-current assets) have fair value measurements which are all based on quoted prices in active markets for identical assets or liabilities. For derivatives (as part of other current assets or accrued liabilities) the fair value is based upon significant other observable inputs depending on the nature of the derivative. The up to $50 million earn-out receivable related to the divested MEMS sensor business in the first quarter of 2026 is measured at fair value using Level 3 inputs.
Assets and liabilities recorded at fair value on a non-recurring basis
We measure and record our non-marketable equity securities, equity method investments and non-financial assets, such as intangible assets and property, plant and equipment, at fair value when an impairment charge is required.
Assets and liabilities not recorded at fair value on a recurring basis
Financial instruments not recorded at fair value on a recurring basis include non-marketable equity securities and equity method investments that have not been remeasured or impaired in the current period and debt.
As of March 29, 2026, the estimated fair value of current and non-current debt was $10.9 billion ($11.6 billion as of December 31, 2025). The fair value is estimated on the basis of broker-dealer quotes and other observable inputs, which are Level 2 inputs. Accrued interest is included under accrued liabilities and not within the carrying amount or estimated fair value of debt.
12 Commitments and Contingencies
Purchase Commitments
The Company maintains purchase commitments with certain suppliers, primarily for raw materials, semi-finished goods and manufacturing services and for some non-production items. Purchase commitments for inventory materials are generally restricted to a forecasted time-horizon as mutually agreed upon between the parties. This forecasted time horizon can vary for different suppliers. As of March 29, 2026, other than foundry joint venture commitments, the Company had purchase commitments of $2,881 million, which are due through 2044.
Foundry Joint Venture Commitments
Driven by our investment in VSMC, NXP has committed to invest an additional $773 million in equity through 2027. NXP has committed to contribute an additional $156 million to support the long-term capacity infrastructure that is expected to be paid through 2026. In addition, NXP has an agreed purchase commitment with VSMC that over the lifetime of the factory the
minimal loading will be between 80% - 90%, resulting in a total purchase commitment of approximately $14,096 million that is expected to be purchased over 37 years once wafer production starts.
Related to our investment in ESMC, NXP has committed to invest an additional $398 million in equity through 2029.
Lease Commitments
The Company has operating and finance lease arrangements related to buildings (corporate offices, research and development and manufacturing facilities and datacenters), land, machinery and installations and other equipment (vehicles and certain office equipment). As of March 29, 2026, amounts related to future lease payments for operating lease obligations totaled $683 million (December 31, 2025: $519 million), which are due through 2048. The increase is primarily attributable to the execution of new relocation lease agreements during the first quarter of 2026.
Legal Proceedings
We are regularly involved as plaintiffs or defendants in claims and litigation relating to a variety of matters such as contractual disputes, personal injury claims, employee grievances and intellectual property litigation. In addition, our acquisitions, divestments and financial transactions sometimes result in, or are followed by, claims or litigation. Some of these claims may possibly be recovered from insurance reimbursements. Although the ultimate disposition of asserted claims cannot be predicted with certainty, it is our belief that the outcome of any such claims, either individually or on a combined basis, will not have a material adverse effect on our consolidated financial position. However, such outcomes may be material to our consolidated statement of operations for a particular period. The Company records an accrual for any claim that arises whenever it considers that it is probable that it is exposed to a loss contingency, and the amount of the loss contingency can be reasonably estimated. The Company does not record a gain contingency until the period in which all contingencies are resolved, and the gain is realized or realizable. Legal fees are expensed when incurred.
Motorola Personal Injury Lawsuits
The Company has assisted Motorola in the defense of personal injury lawsuits pursuant to indemnity obligations under the agreement that separated Freescale from Motorola in 2004. All pending cases were settled as of the end of the first quarter of 2026. As a result, there are no remaining pending lawsuits related to these matters. Accordingly, the Company does not anticipate any further financial impact arising from these claims once settled. A portion of any indemnity due to Motorola will be reimbursed to NXP if Motorola receives an indemnification payment from its insurance coverage.
Legal Proceedings Related Accruals and Insurance Coverage
The Company reevaluates at least on a quarterly basis the claims that have arisen to determine whether any new accruals need to be made or whether any accruals made need to be adjusted based on the most current information available to it and based on its best estimate. Based on the procedures described above, the Company has an aggregate amount of $76 million accrued for potential and current legal proceedings as of March 29, 2026, compared to $75 million accrued at December 31, 2025 (without reduction for any related insurance reimbursements). The accruals are included in “Other current liabilities” and in “Other non-current liabilities”. As of March 29, 2026, the Company’s related balance of insurance reimbursements was $67 million (December 31, 2025: $56 million) and is included in “Other current assets”.
The Company also estimates the aggregate range of reasonably possible losses in excess of the amount accrued based on currently available information for those cases for which such estimate can be made. Given that the known pending legal proceedings with a potentially material aggregate exposure of possible losses were settled during the quarter, the Company does not reasonably anticipate any additional potential aggregate exposure of possible loss in excess of the amount accrued.
Previous: Cover and table of contents · Next: Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations